How Enterprise Value to EBITDA Ratio

How Enterprise Value to EBITDA Ratio Can Help Uncover Profitable Stocks

We often discuss the P/E Ratio for comparing the stocks in the same sectors. However, there are other prudent and simple valuation ratios a retail investor can use in selecting the stocks for their investments. In this article, we are going to discuss, one of such ratios. That is EV/EBITDA.

EV/EBITDA is a popular valuation multiple used widely in the equity research. Enterprise Value (EV) is considered an alternative to Market capitalization, while Earnings Before Interest, Tax, Depreciation, and Amortization (EBITDA) is the operating profit made by a company.

 

Enterprise Value Formula & its importance:

The components of the Enterprise Value are Market Capitalization, Debit and Cash.

The formula of Enterprise Value is Market Capitalization + Debt – Cash.

Let us check an illustration to calculate, a pharmaceuticals LTD.

Pharmaceuticals LTD

Market Capitalization (Cr)

Rs. 15,000.00

Debt (Cr)

Rs. 800.00

cash

Rs. 3,000.00

Enterprise Value (Cr)

Rs. 12,800.00

 

Thus, if a company is acquiring Pharmaceuticals Limited, then the acquirer will get the Assets and liabilities of the company as well, so theoretically the one has to pay Rs.12,800/- to acquire the company.

 

EBITDA Formula & its importance:

The components of EBITDA are Earnings, Interest, Tax, Depreciation & Amortization.

The formula of EBITDA is Operating Income + Depreciation & Amortization

Let us check the illustration of the same company we used in the calculation of Enterprise Value (EV)

Pharmaceuticals LTD

Operating Income (Cr)

Rs. 1,000.00

Depreciation & Amortization (Cr)

Rs. 150.00

EBITDA (Cr)

Rs.850.00

 

The operating income considers only the profit achieved from a company’s business operations, while net profit includes the expenses at the accounts level. So, the EBITDA growth of a company mirrors the growth achieved by a business through its core operations.

 

EV/EBITDA as a Valuation Method:

To arrive at a fair value of a company using the method of EV/EBITDA, the ratio compares the relativity of Enterprise Value to the Operating Income and takes debt and income generated through core operations of the company are taken into consideration.

In the above case, the EV/EBITDA multiple is 15.05

Pharmaceuticals LTD

Enterprise Value (Cr)

Rs. 12,800.00

EBITDA (Cr)

Rs. 850.00

EV/EBITDA

15.05

 

Thus, EV/EBITDA can be used as an alternative to the P/E Ratio because of the added advantage of EV/EBITDA taking debt and earnings from the core operations of the business into account.

The EV/EBITDA will compare the companies from a similar sector, the lower the EV/EBITDA multiple, the better the company.

 

For further queries regarding investments, investment planning and guidance, please call us at +91 7305923322

To read more posts from ATS, check our blog at https://adityatrading.in/

To read more on different types of financial goals, Click Here

Please write to us at research@adityatrading.com

Post a Comment
Error message
Error message
Error message

 

DISCLAIMER

This report is only for the information of our customers. Recommendations, opinions, or suggestions are given with the understanding that readers acting on this information assume all risks involved. The information provided herein is not to be construed as an offer to buy or sell securities of any kind. ATS and/or its group companies do not as assume any responsibility or liability resulting from the use of such information.

 

 

<